Perceptive Advisors as of March 31, 2022
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 135 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Travere Therapeutics Note 2.250% 3/0 (Principal) | 9.5 | $474M | 45M | 10.54 | |
| Amicus Therapeutics (FOLD) | 5.2 | $261M | 28M | 9.47 | |
| Springworks Therapeutics (SWTX) | 5.1 | $256M | 4.5M | 56.44 | |
| Lianbio Sponsored Ads (LIANY) | 4.2 | $209M | 56M | 3.71 | |
| Iovance Biotherapeutics (IOVA) | 4.1 | $203M | 12M | 16.65 | |
| Mirati Therapeutics | 3.9 | $196M | 2.4M | 82.22 | |
| Agile Therapeutics | 3.6 | $178M | 21M | 8.38 | |
| Cerevel Therapeutics Hldng I (CERE) | 3.6 | $178M | 5.1M | 35.01 | |
| Horizon Therapeutics SHS | 2.9 | $143M | 1.4M | 105.21 | |
| Global Blood Therapeutics In | 2.7 | $135M | 3.9M | 34.64 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.3 | $113M | 5.2M | 21.95 | |
| Meiragtx Holdings (MGTX) | 1.9 | $96M | 6.9M | 13.85 | |
| Prometheus Biosciences | 1.8 | $92M | 2.4M | 37.76 | |
| Collegium Pharmaceutical Note 2.625% 2/1 (Principal) | 1.8 | $90M | 9.5M | 9.42 | |
| Iveric Bio | 1.8 | $88M | 5.2M | 16.83 | |
| Vbi Vaccines Inc Cda Com New | 1.7 | $87M | 52M | 1.66 | |
| Outset Med (OM) | 1.7 | $86M | 1.9M | 45.40 | |
| Apellis Pharmaceuticals (APLS) | 1.5 | $75M | 1.5M | 50.81 | |
| Xenon Pharmaceuticals (XENE) | 1.5 | $74M | 2.4M | 30.57 | |
| Albireo Pharma | 1.4 | $70M | 2.4M | 29.83 | |
| Rapt Therapeutics (RAPT) | 1.2 | $62M | 2.8M | 21.99 | |
| Coherus Biosciences (CHRS) | 1.2 | $61M | 4.7M | 12.91 | |
| Relay Therapeutics (RLAY) | 1.2 | $58M | 1.9M | 29.93 | |
| Bellus Health Com New | 1.1 | $56M | 8.1M | 6.88 | |
| Procept Biorobotics Corp (PRCT) | 1.0 | $52M | 1.5M | 34.99 | |
| C4 Therapeutics Com Stk (CCCC) | 1.0 | $51M | 2.1M | 24.26 | |
| Travere Therapeutics (TVTX) | 1.0 | $48M | 1.8M | 25.77 | |
| Athira Pharma (ATHA) | 0.9 | $46M | 3.4M | 13.50 | |
| Coherus Biosciences Note 1.500% 4/1 (Principal) | 0.9 | $45M | 4.5M | 9.91 | |
| Aldeyra Therapeutics (ALDX) | 0.9 | $44M | 9.9M | 4.45 | |
| Chemocentryx | 0.8 | $42M | 1.7M | 25.07 | |
| Cincor Pharma | 0.8 | $41M | 2.3M | 17.54 | |
| Inhibrx (INBX) | 0.8 | $40M | 1.8M | 22.28 | |
| Nautilus Biotechnology (NAUT) | 0.8 | $40M | 9.1M | 4.34 | |
| Bridgebio Pharma (BBIO) | 0.8 | $39M | 3.8M | 10.15 | |
| Neurocrine Biosciences (NBIX) | 0.7 | $37M | 396k | 93.75 | |
| Zymeworks | 0.7 | $35M | 5.3M | 6.55 | |
| Nevro (NVRO) | 0.7 | $35M | 477k | 72.33 | |
| Penumbra (PEN) | 0.6 | $32M | 144k | 222.13 | |
| Morphic Hldg (MORF) | 0.6 | $31M | 767k | 40.15 | |
| Establishment Labs Holdings Ord (ESTA) | 0.6 | $30M | 450k | 67.39 | |
| Alnylam Pharmaceuticals (ALNY) | 0.6 | $29M | 180k | 163.29 | |
| Verrica Pharmaceuticals (VRCA) | 0.6 | $29M | 3.6M | 8.11 | |
| Dice Therapeutics | 0.6 | $29M | 1.5M | 19.13 | |
| Madrigal Pharmaceuticals (MDGL) | 0.5 | $27M | 278k | 98.12 | |
| Rocket Pharmaceuticals (RCKT) | 0.5 | $27M | 1.7M | 15.86 | |
| Miragen Therapeutics (VRDN) | 0.5 | $26M | 1.4M | 18.49 | |
| Nuvalent Inc-a (NUVL) | 0.5 | $24M | 1.8M | 13.89 | |
| Cogent Biosciences (COGT) | 0.5 | $24M | 3.2M | 7.49 | |
| Caremax Com Cl A | 0.5 | $24M | 3.2M | 7.47 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.5 | $23M | 502k | 46.14 | |
| Singular Genomics Systems In (OMIC) | 0.5 | $23M | 3.7M | 6.31 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.4 | $22M | 616k | 36.34 | |
| Landos Biopharma | 0.4 | $22M | 15M | 1.48 | |
| Adma Biologics (ADMA) | 0.4 | $22M | 12M | 1.83 | |
| Tarsus Pharmaceuticals (TARS) | 0.4 | $22M | 1.3M | 16.82 | |
| Axonics Modulation Technolog (AXNX) | 0.4 | $21M | 341k | 62.60 | |
| Female Health (VERU) | 0.4 | $21M | 4.4M | 4.83 | |
| Immatics SHS (IMTX) | 0.4 | $20M | 2.5M | 7.99 | |
| Quotient SHS | 0.4 | $19M | 16M | 1.20 | |
| Amylyx Pharmaceuticals (AMLX) | 0.4 | $19M | 1.5M | 12.85 | |
| Treace Med Concepts (TMCI) | 0.4 | $18M | 971k | 18.91 | |
| Kronos Bio (KRON) | 0.4 | $18M | 2.4M | 7.23 | |
| Solid Biosciences | 0.3 | $16M | 13M | 1.20 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.3 | $15M | 3.0M | 4.99 | |
| Isoplexis Corp | 0.3 | $14M | 4.1M | 3.43 | |
| Leap Therapeutics | 0.3 | $14M | 8.0M | 1.75 | |
| Macrogenics (MGNX) | 0.3 | $14M | 1.6M | 8.81 | |
| Pulmonx Corp (LUNG) | 0.3 | $13M | 538k | 24.81 | |
| CryoLife (AORT) | 0.3 | $13M | 616k | 21.38 | |
| Lyra Therapeutics (LYRA) | 0.3 | $13M | 3.2M | 4.02 | |
| Health Catalyst (HCAT) | 0.3 | $13M | 494k | 26.13 | |
| Arcus Biosciences Incorporated (RCUS) | 0.3 | $13M | 405k | 31.56 | |
| Rain Therapeutics | 0.3 | $13M | 2.5M | 5.07 | |
| Somalogic Class A Com | 0.2 | $12M | 1.5M | 8.02 | |
| Athenex | 0.2 | $11M | 14M | 0.83 | |
| Nanostring Technologies Note 2.625% 3/0 (Principal) | 0.2 | $11M | 1.0M | 11.04 | |
| Cue Health (HLTH) | 0.2 | $10M | 1.6M | 6.45 | |
| Absci Corp (ABSI) | 0.2 | $10M | 1.2M | 8.43 | |
| Bcls Acquisition Corp Com Cl A | 0.2 | $9.9M | 1.0M | 9.87 | |
| Summit Healthcre Acquistn Unit 06/03/2026 | 0.2 | $9.8M | 1.0M | 9.78 | |
| Research Alliance Corp Ii Com Cl A | 0.2 | $9.8M | 1.0M | 9.76 | |
| Icosavax | 0.2 | $9.7M | 1.4M | 7.04 | |
| Fusion Pharmaceuticals (FUSN) | 0.2 | $9.5M | 1.2M | 7.77 | |
| Point Biopharma Global | 0.2 | $9.5M | 1.2M | 7.97 | |
| Nuvation Bio Com Cl A (NUVB) | 0.2 | $9.3M | 1.8M | 5.26 | |
| Astria Therapeutics (ATXS) | 0.2 | $8.6M | 1.3M | 6.71 | |
| Evolent Health Cl A (EVH) | 0.2 | $8.1M | 250k | 32.30 | |
| Science 37 Holdings | 0.2 | $8.0M | 1.5M | 5.35 | |
| Nanobiotix Sa Sponsored Ads (NBTX) | 0.2 | $7.9M | 1.1M | 7.44 | |
| Sema4 Holdings Corp Com Cl A | 0.2 | $7.7M | 2.5M | 3.07 | |
| Concert Pharmaceuticals I equity | 0.1 | $7.2M | 2.2M | 3.37 | |
| Fulcrum Therapeutics (FULC) | 0.1 | $7.0M | 294k | 23.65 | |
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $6.9M | 285k | 24.22 | |
| Aclaris Therapeutics (ACRS) | 0.1 | $6.6M | 383k | 17.24 | |
| Pyxis Oncology Common Stock (PYXS) | 0.1 | $6.2M | 1.5M | 4.04 | |
| Accolade (ACCD) | 0.1 | $5.8M | 331k | 17.56 | |
| Provention Bio | 0.1 | $5.8M | 792k | 7.32 | |
| Privia Health Group (PRVA) | 0.1 | $5.7M | 213k | 26.73 | |
| Merus N V (MRUS) | 0.1 | $5.5M | 209k | 26.44 | |
| Day One Biopharmaceuticals I (DAWN) | 0.1 | $5.5M | 556k | 9.92 | |
| Clover Health Investments Com Cl A (CLOV) | 0.1 | $5.3M | 1.5M | 3.55 | |
| Hyperfine Com Cl A (HYPR) | 0.1 | $5.3M | 1.5M | 3.54 | |
| Tyra Biosciences (TYRA) | 0.1 | $5.3M | 494k | 10.70 | |
| Envveno Medical (NVNO) | 0.1 | $5.0M | 782k | 6.37 | |
| Da32 Life Scnce Tec Acqstn C Class A Com | 0.1 | $4.9M | 500k | 9.72 | |
| Pear Therapeutics Class A Com (PEARQ) | 0.1 | $4.7M | 926k | 5.05 | |
| Sight Sciences (SGHT) | 0.1 | $4.5M | 390k | 11.56 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.1 | $4.5M | 450k | 9.91 | |
| Invitae (NVTAQ) | 0.1 | $4.4M | 555k | 7.97 | |
| Immuneering Corp Class A Com (IMRX) | 0.1 | $4.4M | 681k | 6.47 | |
| Relmada Therapeutics (RLMD) | 0.1 | $4.1M | 151k | 26.99 | |
| Inari Medical Ord (NARI) | 0.1 | $2.7M | 30k | 90.63 | |
| Revance Therapeutics (RVNC) | 0.1 | $2.7M | 138k | 19.50 | |
| Sonendo (SONX) | 0.1 | $2.7M | 669k | 4.01 | |
| Zymergen | 0.1 | $2.6M | 883k | 2.89 | |
| Prothena Corp SHS (PRTA) | 0.0 | $2.4M | 65k | 36.57 | |
| Acumen Pharmaceuticals (ABOS) | 0.0 | $2.3M | 597k | 3.91 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $2.0M | 384k | 5.11 | |
| Dariohealth Corp Com New (DRIO) | 0.0 | $1.9M | 328k | 5.84 | |
| Graphite Bio | 0.0 | $1.7M | 326k | 5.10 | |
| Reata Pharmaceuticals Cl A | 0.0 | $1.5M | 45k | 32.76 | |
| Ferrari Nv Ord (RACE) | 0.0 | $1.4M | 6.2k | 218.06 | |
| Oncorus | 0.0 | $1.3M | 752k | 1.78 | |
| Rapid Micro Biosystems Class A Com (RPID) | 0.0 | $1.3M | 191k | 6.79 | |
| Motus Gi Hldgs Incorporated | 0.0 | $648k | 1.8M | 0.36 | |
| Neptune Wellness Solutions I | 0.0 | $445k | 2.0M | 0.22 | |
| Rockley Photonics Holdings L *w Exp 08/11/202 | 0.0 | $425k | 500k | 0.85 | |
| Butterfly Network *w Exp 02/12/202 (BFLY.WS) | 0.0 | $238k | 233k | 1.02 | |
| Somalogic *w Exp 08/31/202 | 0.0 | $235k | 110k | 2.14 | |
| Surrozen | 0.0 | $234k | 78k | 3.01 | |
| Minerva Surgical | 0.0 | $226k | 50k | 4.50 | |
| Eqrx *w Exp 12/17/202 | 0.0 | $218k | 250k | 0.87 | |
| Caremax *w Exp 06/08/202 (CMAXW) | 0.0 | $114k | 60k | 1.90 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $42k | 167k | 0.25 |
